IPSEN BIOPHARM LIMITED

LL13 9UF (Wales)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£852,841

Mar 18 - Feb 21

Novel production process for a highly potent recombinant protein using doggybone DNA (dbDNA) vector and cell free expression technology

ISCF award to IPSEN BIOPHARM LIMITED and David Gruber

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}